643.88MMarket Cap-3.52P/E (TTM)
8.530High8.250Low815.08KVolume8.370Open8.280Pre Close6.77MTurnover1.83%Turnover RatioLossP/E (Static)77.76MShares24.17052wk High1.52P/B368.74MFloat Cap6.98052wk Low--Dividend TTM44.53MShs Float43.000Historical High--Div YieldTTM3.38%Amplitude2.500Historical Low8.305Avg Price1Lot Size
Kura Oncology Stock Forum
Kura Oncology Expands Team with Strategic Stock Options Package - Inside the $8.25/Share Deal
Major Clinical Success: AML Drug Breakthrough Shows Promise for Blood Cancer Patients
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology | KURA Stock News
$Kura Oncology (KURA.US)$
No comment yet